Chieh-Ju Lu, D.Phil
Chieh-Ju Lu, D.Phil. completed his postdoctoral fellowship training at University of British Columbia. Michael Smith Laboratories, 2016-2019; University of Oxford, D.Phil. (Ph.D.) Degree - Physiology, Anatomy & Genetics, 2010-2015; Imperial College London, M.Sc. Degree - Pathology of Viruses and Molecular Biology, 2009- 2010; and University College London, B.Sc. Degree - Biomedical Science, 2006-2009.
Chieh-Ju is a research scientist with over 9 years of experience in biomedical research, including years of cross-functional project management, stakeholders management, and customer-facing experience. His multi-disciplined background includes drug (biologics) development, translational research and genetic engineering. In addition, he is an innovative copywriter with a passion for business development, product marketing and content communication.
What is the Value of iPSC Technology in Cardiac Research?
Induced pluripotent stem cells (iPSCs) are important tools in many areas of cardiac research including disease modeling, drug development & transplantation.
The Promising Future of Nanomedicine and Nanoparticles
Nanomedicine and nanoparticles have the potential to revolutionize cancer therapeutics because they should be able to deliver the drug with more precision.